2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/ SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary
ACCF/AHA Task Force on Practice Guidelines.Manual for ACCF/ AHA Guideline Writing Committees: Methodologies and Policies from the ACCF/AHA Task Force on Practice Guidelines . Available at: http://assets.cardiosource.com/Methodology_Manual_for_ACC_AHA_Writing_Committees.pdfandhttp://circ.ahajournals.org/manual/. Accessed October 1, 2010.
2.
Adams HP Jr. , del Zoppo GJ, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups [published corrections appear in Stroke. 2007 ;38:e38 and Stroke2007;38: e96]. Stroke. 2007 ;38:1655-711
3.
Rashid P., Leonardi-Bee J., Bath P.Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke2003;34:2741-8.
4.
Sacco RL, Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke. Stroke2006;37:577-617.
5.
PROGRESS Collaborative Group Randomised trial of a perindoprilbased blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet2001 ;358: 1033-41.
6.
Lawes CM, Bennett DA, Feigin VL, et al. Blood pressure and stroke: an overview of published reviews . Stroke2004;35:776-85.
7.
Neal B., MacMahon S., Chapman N., et al. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet2000;356:1955-64.
8.
Wolf PA, D’Agostino RB, Kannel WB, et al. Cigarette smoking as a risk factor for stroke: the Framingham Study. JAMA1988;259: 1025-9.
9.
Shinton R., Beevers G.Meta-analysis of relation between cigarette smoking and stroke. BMJ1989;298:789-94.
10.
Kawachi I., Colditz GA, Stampfer MJ, et al. Smoking cessation and decreased risk of stroke in women. JAMA1993;269:232-6.
11.
Robbins AS, Manson JE, Lee IM, et al. Cigarette smoking and stroke in a cohort of U.S. male physicians . Ann Intern Med1994;120: 458-62.
12.
Wannamethee SG, Shaper AG, Whincup PH, et al. Smoking cessation and the risk of stroke in middle-aged men. JAMA1995;274: 155-60.
13.
Amarenco P. , Bogousslavsky J., Callahan A.III et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med2006;355:549-59.
14.
Adams RJ, Albers G., Alberts MJ, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke2008;39:1647-52.
15.
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation2002;106:3143-421.
16.
Frick MH, Elo O., Haapa K., et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med1987;317:1237-45.
17.
Kris-Etherton PM, Harris WS, Appel LJFish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation2002;106:2747-57.
18.
Rubins HB , Robins SJ, Collins D., et al. , Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med1999 ;341:410-8.
19.
Brown BG, Zhao XQ, Chait A., et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med2001;345:1583-92.
20.
Gerstein HC , Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med2008;358:2545-59.
21.
Patel A., MacMahon S., Chalmers J., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med2008;358:2560-72.
22.
Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet2004;364:685-96.
23.
Goldstein LB , Adams R., Alberts MJ, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group . Stroke2006;37:1583-633.
24.
The Canadian Cooperative Study GroupA randomized trial of aspirin and sulfinpyrazone in threatened stroke . N Engl J Med1978;299:53-9.
25.
Antithrombotic Trialists’ Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ2002;324:71-86.
26.
CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) . Lancet1996;348:1329-39.
27.
Diener HC, Bogousslavsky J., Brass LM, et al. Aspirin and clopidogrel compad with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet2004;364:331-7.
28.
Diener HC, Cunha L., Forbes C., et al. European Stroke Prevention Study: 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci1996;143:1-13.
29.
Sacco RL, Diener HC, Yusuf S., et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med2008;359:1238-51.
30.
Mohr JP, Thompson JL, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med2001;345:1444-51.
31.
Halkes PH, van Gijn J., Kappelle LJ, et al. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial. Lancet Neurol2007;6: 115-24.
32.
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med1994;154:1449-57.
33.
Woessner R. , Grauer M., Bianchi O., et al. Treatment with anticoagulants in cerebral events (TRACE). Thromb Haemost2004;91:690-3.
34.
The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA1998;279:1265-72.
35.
Barnett HJ, Taylor DW, Eliasziw M., et al. , North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med1998;339:1415-25.
36.
Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet1998;351:1379-87.
37.
National Institute of Neurological Disorders and Stroke Stroke and Trauma Division North American Symptomatic Carotid Endarterectomy Trial (NASCET) Investigators.Clinical alert: benefit of carotid endarterectomy for patients with high-grade stenosis of the internal carotid artery. Stroke1991;22:816-7.
38.
Rothwell PM , Slattery J., Warlow CPA systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Stroke1996;27:260-5.
39.
Brott TG, Hobson RW, Howard G., et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med2010;363:11-23.
40.
Hobson RW, Weiss DG, Fields WS, et al. , The Veterans Affairs Cooperative Study Group. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med1993;328:221-7.
41.
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study Endarterectomy for asymptomatic carotid artery stenosis. JAMA1995;273:1421-8.
42.
Gray WA, Hopkins LN, Yadav S., et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg2006;44:258-68.
43.
Katzen BT, Criado FJ, Ramee SR, et al. Carotid artery stenting with emboli protection surveillance study: thirty-day results of the CASES-PMS study. Catheter Cardiovasc Interv2007;70:316-23.
44.
Rothwell PM , Goldstein LBCarotid endarterectomy for asymptomatic carotid stenosis: asymptomatic carotid surgery trial. Stroke2004;35:2425-7.
45.
Eckstein HH , Ringleb P., Allenberg JR, et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol2008;7:893-902.
46.
Chiam PT, Roubin GS, Panagopoulos G., et al. One-year clinical outcomes, midterm survival, and predictors of mortality after carotid stenting in elderly patients. Circulation2009;119:2343-8.
47.
Roubin GS, New G., Iyer SS, et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation2001;103:532-7.
48.
Zahn R., Ischinger T., Hochadel M., et al. Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) Registry. Eur Heart J2007;28:370-5.
49.
Ederle J., Dobson J., Featherstone RL, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet2010;375:985-97.
50.
Gurm HS, Yadav JS, Fayad P., et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med2008;358:1572-9.
51.
Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med2004;351:1493-501.
52.
Yadav JS, Sneed D., Ouriel K., et al. Durability of carotid stenting for the prevention of stroke: 3-year follow-up of the SAPPHIRE trial and the US Carotid Feasibility. Circulation2005;112:416. Abstract
53.
Gray WA, Yadav JS, Verta P., et al. The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting. Catheter Cardiovasc Interv2007;69:341-8.
54.
Harrod-Kim P., Kadkhodayan Y., Derdeyn CP, et al. Outcomes of carotid angioplasty and stenting for radiation-associated stenosis. AJNR Am J Neuroradiol2005;26:1781-8.
55.
Rothwell PM , Eliasziw M., Gutnikov SA, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet2004;363:915-24.
56.
Bates ER, Babb JD, Casey DE Jr.et al. Accf/Scai/Svmb/Sir/ Asitn2007clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/ SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). J Am Coll Cardiol2007;49:126-70.
57.
Safian RD , Bacharach JM, Ansel GM, et al. Carotid stenting with a new system for distal embolic protection and stenting in high-risk patients: the carotid revascularization with ev3 arterial technology evolution (CREATE) feasibility trial. Catheter Cardiovasc Interv2004 ;63:1-6.
58.
White CJ, Iyer SS, Hopkins LN, et al. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Catheter Cardiovasc Interv2006;67:503-12.
Taylor DW , Barnett HJ, Haynes RB, et al., ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. Lancet1999 ;353:2179-84.
61.
Bhatt DL, Fox KA, Hacke W., et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med2006 ;354:1706-17.
62.
AbuRahma AF , Robinson PA, Saiedy S., et al. Prospective randomized trial of bilateral carotid endarterectomies: primary closure versus patching. Stroke1999 ;30:1185-9.
63.
Bond R., Rerkasem K., AbuRahma AF, et al. Patch angioplasty versus primary closure for carotid endarterectomy . Cochrane Database Syst Rev2004;CD000160
64.
Lamuraglia GM, Stoner MC, Brewster DC, et al. Determinants of carotid endarterectomy anatomic durability: effects of serum lipids and lipid-lowering drugs. J Vasc Surg2005;41:762-8.
65.
Roth SM, Back MR, Bandyk DF, et al. A rational algorithm for duplex scan surveillance after carotid endarterectomy. J Vasc Surg1999;30:453-60.
66.
Garg N., Karagiorgos N., Pisimisis GT, et al. Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting: a systematic review of the current literature . J Endovasc Ther2009;16:412-27.
67.
Mas JL, Chatellier G., Beyssen B., et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med2006 ;355:1660-71.
68.
Ginsberg HN , Kris-Etherton P., Dennis B., et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol1998;18:441-9.
69.
Antiplatelet Trialists’ Collaboration Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ1994;308:81-106.
70.
Berguer R., Morasch MD, Kline RA, et al. Cervical reconstruction of the supra-aortic trunks: a 16-year experience. J Vasc Surg1999;29:239-46.
71.
Moore WS, Malone JM, Goldstone J.Extrathoracic repair of branch occlusions of the aortic arch. Am J Surg1976;132:249-57.
72.
Modarai B., Ali T., Dourado R., et al. Comparison of extra-anatomic bypass grafting with angioplasty for atherosclerotic disease of the supra-aortic trunks. Br J Surg2004;91:1453-7.
73.
Cho L., Mukherjee D.Basic cerebral anatomy for the carotid interventionalist: the intracranial and extracranial vessels. Catheter Cardiovasc Interv2006;68:104-11.
74.
Layton KF, Kallmes DF, Cloft HJ, et al. Bovine aortic arch variant in humans: clarification of a common misnomer. AJNR Am J Neuroradiol2006;27:1541-2.
75.
Wolf PA, Clagett GP, Easton JD, et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke1999;30:1991-4.
76.
Centers for Disease Control and Prevention Prevalence of disabilities and associated health conditions among adults-United States, 1999. MMWR Morb Mortal Wkly Rep2001;50:120-5.
77.
Pickett CA, Jackson JL, Hemann BA, et al. Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis. Lancet2008;371:1587-94.
78.
Wiebers DO, Whisnant JP, Sandok BA, et al. Prospective comparison of a cohort with asymptomatic carotid bruit and a population-based cohort without carotid bruit. Stroke1990;21:984-8.
79.
Norris JW, Zhu CZ, Bornstein NM, et al. Vascular risks of asymptomatic carotid stenosis. Stroke1991;22:1485-90.
80.
Kuller LH, Arnold AM, Psaty BM, et al. 10-year follow-up of subclinical cardiovascular disease and risk of coronary heart disease in the Cardiovascular Health Study. Arch Intern Med2006;166:71-8.
81.
Arnold AM, Psaty BM, Kuller LH, et al. Incidence of cardiovascular disease in older Americans: the Cardiovascular Health Study. J Am Geriatr Soc2005;53:211-8.
82.
ICAVL standards for accreditation in noninvasive vascular testing: part II: vascular laboratory operations. extracranial cerebrovascular testing. http://www.icavl.org/icavl/pdfs/extracranial2007.pdf . Accessed August 29, 2008
83.
ICAVL standards for accreditation in noninvasive vascular testing . http://www.icavl.org/icavl/apply/standards.htm
84.
Young B., Moore WS, Robertson JT, et al. An analysis of perioperative surgical mortality and morbidity in the asymptomatic carotid atherosclerosis study. Asymptomatic Carotid Artheriosclerosis Study. Stroke1996;27:2216-24.
85.
Halliday AW , Thomas D., Mansfield A., et al. The Asymptomatic Carotid Surgery Trial (ACST): rationale and design. Steering Committee. Eur J Vasc Surg1994;8:703-10.
86.
North American Symptomatic Carotid Endarterectomy Trial Collaborators Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med1991;325:445-53.
87.
Hertzer NR, Flanagan RA Jr., Beven EG, et al. Surgical versus non-operative treatment of asymptomatic carotid stenosis. 290 patients documented by intravenous angiography. Ann Surg1986;204: 163-71.
88.
Spence JD, Coates V., Li H., et al. Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol2010;67:180-6.
89.
Marquardt L. , Geraghty OC, Mehta Z., et al. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke2010;41: e11-7.
90.
Abbott AL, Chambers BR, Stork JL, et al. Embolic signals and prediction of ipsilateral stroke or transient ischemic attack in asymptomatic carotid stenosis: a multicenter prospective cohort study. Stroke2005;36:1128-33.
91.
Goessens BM , Visseren FL, Kappelle LJ, et al. Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease: the SMART study. Stroke2007;38:1470-5.
92.
Mayberg MR, Wilson SE, Yatsu F., et al. , Veterans Affairs Cooperative Studies Program 309 Trialist Group. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. JAMA1991;266:3289-94.
93.
Halliday A. , Mansfield A., Marro J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet2004;363:1491-502.
94.
Fisher M., Paganini-Hill A., Martin A., et al. Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. Stroke2005; 36:253-7.
95.
Lal BK, Hobson RW, Pappas PJ, et al. Pixel distribution analysis of B-mode ultrasound scan images predicts histologic features of atherosclerotic carotid plaques. J Vasc Surg2002;35:1210-7.
96.
Redgrave JN , Coutts SB, Schulz UG, et al. Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack . Stroke2007;38:1482-8.
97.
Adams HP Jr. , Adams RJ , Brott T., et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke2003;34:1056-83.
98.
Williams JE , Rosamond WD, Morris DLStroke symptom attribution and time to emergency department arrival: the delay in accessing stroke healthcare study. Acad Emerg Med2000;7:93-6.
99.
Lisabeth LD , Ireland JK, Risser JM, et al. Stroke risk after transient ischemic attack in a population-based setting. Stroke2004;35: 1842-6.
100.
Kleindorfer D., Panagos P., Pancioli A., et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study . Stroke2005;36:720-3.
101.
Lovett JK , Dennis MS, Sandercock PA, et al. Very early risk of stroke after a first transient ischemic attack . Stroke2003;34:e138-40.
102.
Johnston SC , Easton JDAre patients with acutely recovered cerebral ischemia more unstable?. Stroke2003;34:2446-50.
103.
Fisher M.Stroke and TIA: epidemiology, risk factors, and the need for early intervention . Am J Manag Care2008;14:S204-11.
104.
Heyman A. , Wilkinson WE, Hurwitz BJ, et al. Risk of ischemic heart disease in patients with TIA. Neurology1984;34:626-30.
105.
Dennis M. , Bamford J., Sandercock P., et al. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke1990;21:848-53.
106.
Whisnant JPClinical epidemiology in transient cerebral ischemic attacks (TIA) in the anterior and posterior circulation. Sundt TM, editor. Occlusive Cerebrovascular Disease: Diagnosis and Surgical Management1987;Philadelphia, Pa: W.B. Saunders Co, 60-5.
107.
Naylor AROccam’s razor: intervene early to prevent more strokes!. J Vasc Surg2008;48:1053-9.
108.
Gautier JCAmaurosis fugax. N Engl J Med1993;329:426-8.
109.
Benavente O., Eliasziw M., Streifler JY, et al. Prognosis after transient monocular blindness associated with carotid-artery stenosis . N Engl J Med2001;345:1084-90.
110.
Gaul JJ, Marks SJ, Weinberger J.Visual disturbance and carotid artery disease: 500 symptomatic patients studied by non-invasive carotid artery testing including B-mode ultrasonography . Stroke1986;17:393-8.
111.
Gallego CJ , Herrera M., Navarro M.Ophthalmological manifestations of cerebrovascular disease [in Spanish]. An Sist Sanit Navar2008;31 Suppl3:111-26
112.
Grant EG, Benson CB, Moneta GL, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis-Society of Radiologists in Ultrasound Consensus Conference. Radiology2003;229:340-6.
113.
Grant EG, Duerinckx AJ, El Saden SM, et al. Ability to use duplex US to quantify internal carotid arterial stenoses: fact or fiction?. Radiology2000 ;214:247-52.
114.
Long A., Lepoutre A., Corbillon E., et al. Critical review of non- or minimally invasive methods (duplex ultrasonography, MR- and CT-angiography) for evaluating stenosis of the proximal internal carotid artery. Eur J Vasc Endovasc Surg2002;24:43-52.
115.
Cowper SE, Kuo PH, Bucala R.Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders. Arthritis Rheum2007;56:3173-5.
116.
Chen CJ, Lee TH, Hsu HL, et al. Multi-slice CT angiography in diagnosing total versus near occlusions of the internal carotid artery: comparison with catheter angiography. Stroke2004;35:83-5.
Eisenberg RL, Bank WO, Hedgcock MWNeurologic complications of angiography in patients with critical stenosis of the carotid artery. Neurology1980;30:892-5.
119.
Earnest F. , Forbes G., Sandok BA, et al. Complications of cerebral angiography: prospective assessmegsnt of risk. AJR Am J Roentgenol1984;142:247-53.
120.
Dion JE, Gates PC, Fox AJ, et al. Clinical events following neuroangiography: a prospective study . Stroke1987;18:997-1004.
121.
Grzyska U. , Freitag J., Zeumer H.Selective cerebral intraarterial DSA: complication rate and control of risk factors. Neuroradiology1990;32:296-9.
Hankey GJ, Warlow CP, Molyneux AJComplications of cerebral angiography for patients with mild carotid territory ischaemia being considered for carotid endarterectomy. J Neurol Neurosurg Psychiatry1990;53:542-8.
124.
Davies KN, Humphrey PRComplications of cerebral angiography in patients with symptomatic carotid territory ischaemia screened by carotid ultrasound. J Neurol Neurosurg Psychiatry1993;56: 967-72.
125.
Leonardi M. , Cenni P., Simonetti L., et al. Retrospective study of complications arising during cerebral and spinal diagnostic angiography from 1998 to 2003 . Interv Neuroradiol2005 ;11:213-21.
126.
MacMahon S. , Peto R., Cutler J., et al. Blood pressure, stroke, and coronary heart disease. part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet1990;335:765-74.
127.
Rodgers A. , MacMahon S., Gamble G., et al. Blood pressure and risk of stroke in patients with cerebrovascular disease: the United Kingdom Transient Ischaemic Attack Collaborative Group. BMJ1996;313:147
128.
Lewington S., Clarke R., Qizilbash N., et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet2002;360:1903-13.
129.
Heiss G., Sharrett AR, Barnes R., et al. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol1991;134:250-6.
130.
Howard G., Manolio TA, Burke GL, et al., The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health Study (CHS) Investigators Does the association of risk factors and atherosclerosis change with age?. An analysis of the combined ARIC and CHS cohorts. Stroke1997;28:1693-701.
131.
Wilson PW, Hoeg JM, D’Agostino RB, et al. Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N Engl J Med1997;337:516-22.
132.
Psaty BM, Arnold AM, Olson J., et al. Association between levels of blood pressure and measures of subclinical disease. Multi-Ethnic Study of Atherosclerosis. Am J Hypertens2006;19:1110-7.
133.
Tell GS, Rutan GH, Kronmal RA, et al. , Cardiovascular Health Study (CHS) Collaborative Research Group. Correlates of blood pressure in community-dwelling older adults: the Cardiovascular Health Study. Hypertension1994;23:59-67.
134.
Crouse JR, Toole JF, McKinney WM, et al. Risk factors for extracranial carotid artery atherosclerosis . Stroke1987;18:990-6.
135.
Yusuf S., Sleight P., Pogue J., et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med2000;342:145-53.
136.
Rohr J., Kittner S., Feeser B., et al. Traditional risk factors and ischemic stroke in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Arch Neurol1996;53:603-7.
137.
Howard G., Wagenknecht LE, Cai J., et al. Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke1998;29:913-7.
138.
Lu M., Ye W., Adami HO, et al. Stroke incidence in women under 60 years of age related to alcohol intake and smoking habit. Cerebrovasc Dis2008;25:517-25.
139.
Wasserman BA, Sharrett AR, Lai S., et al. Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the Multi-Ethnic Study of Atherosclerosis (MESA). Stroke2008;39:329-35.
140.
Briel M., Studer M., Glass TR, et al. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials . Am J Med2004;117:596-606.
141.
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet2002;360:7-22.
142.
Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med1991;151:1141-7.
143.
Karapanayiotides T., Piechowski-Jozwiak B., van Melle G., et al. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology2004;62:1558-62.
144.
Folsom AR, Rasmussen ML, Chambless LE, et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care1999;22: 1077-83.
145.
Laakso M.Benefits of strict glucose and blood pressure control in type 2 diabetes: lessons from the UK Prospective Diabetes Study. Circulation1999;99:461-2.
146.
Nathan DM , Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med2005;353:2643-53.
147.
UK-TIA Study Group United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. Br Med J (Clin Res Ed)1988;296:316-20.
148.
Keech A., Simes RJ, Barter P., et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet2005;366:1849-61.
149.
Keech A., Simes J., Barter P., et al. Correction to the FIELD study report. Lancet2006;368:1415.
150.
McNeill AM , Rosamond WD, Girman CJ, et al. Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (the ARIC Study). Am J Cardiol2004;94:1249-54.
151.
Montalcini T. , Gorgone G., Federico D., et al. Association of LDL cholesterol with carotid atherosclerosis in menopausal women affected by the metabolic syndrome . Nutr Metab Cardiovasc Dis2005;15:368-72.
152.
Kawamoto R. , Ohtsuka N., Ninomiya D., et al. Carotid atherosclerosis in normal-weight metabolic syndrome. Intern Med2007;46:1771-7.
153.
Rundek T., White H., Boden-Albala B., et al. The metabolic syndrome and subclinical carotid atherosclerosis: the Northern Manhattan Study. J Cardiometab Syndr2007;2:24-9.
154.
Montalcini T., Gorgone G., Gazzaruso C., et al. Carotid atherosclerosis associated to metabolic syndrome but not BMI in healthy menopausal women. Diabetes Res Clin Pract2007;76:378-82.
155.
Kawamoto R. , Tomita H., Inoue A., et al. Metabolic syndrome may be a risk factor for early carotid atherosclerosis in women but not in men. J Atheroscler Thromb2007;14:36-43.
156.
Ishizaka N. , Ishizaka Y., Toda E., et al. Association between cigarette smoking, metabolic syndrome, and carotid arteriosclerosis in Japanese individuals. Atherosclerosis2005;181:381-8.
157.
Wallenfeldt K., Hulthe J., Fagerberg B.The metabolic syndrome in middle-aged men according to different definitions and related changes in carotid artery intima-media thickness (IMT) during 3 years of follow-up . J Intern Med2005;258:28-37.
158.
Iglseder B. , Cip P., Malaimare L., et al. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke2005;36:1212-7.
159.
Scuteri A. , Najjar SS, Muller DC, et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness . J Am Coll Cardiol2004;43:1388-95.
160.
Kawamoto R. , Tomita H., Oka Y., et al. Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis . Intern Med2005;44:1232-8.
161.
Kawamoto R. , Tomita H., Oka Y., et al. Metabolic syndrome and carotid atherosclerosis: role of elevated blood pressure. J Atheroscler Thromb2005;12:268-75.
162.
Irace C., Cortese C., Fiaschi E., et al. Components of the metabolic syndrome and carotid atherosclerosis: role of elevated blood pressure. Hypertension2005;45:597-601.
163.
Teramura M. , Emoto M., Araki T., et al. Clinical impact of metabolic syndrome by modified NCEP-ATP III criteria on carotid atherosclerosis in Japanese adults . J Atheroscler Thromb2007;14:172-8.
164.
Empana JP, Zureik M., Gariepy J., et al. The metabolic syndrome and the carotid artery structure in noninstitutionalized elderly subjects: the three-city study. Stroke2007;38:893-9.
165.
Winter Y., Rohrmann S., Linseisen J., et al. Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke2008 ;39:3145-51.
166.
Goldstein LB, Adams R., Becker K., et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation2001;103:163-82.
167.
North American Symptomatic Carotid Endarterectomy Trial: methods, patient characteristics, and progress. Stroke1991;22:711-20.
168.
Goldstein LB, Hasselblad V., Matchar DB, et al. Comparison and meta-analysis of randomized trials of endarterectomy for symptomatic carotid artery stenosis. Neurology1995;45:1965-70.
169.
Rothwell PM , Eliasziw M., Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet2003 ;361:107-16.
170.
Rothwell PM , Gutnikov SA, Warlow CPReanalysis of the final results of the European Carotid Surgery Trial. Stroke2003;34: 514-23.
171.
Mas JL , Trinquart L., Leys D., et al. Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol2008;7:885-92.
172.
Bonati LH, Jongen LM, Haller S., et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol2010;9:353-62.
173.
Suissa S.Calculation of number needed to treat. N Engl J Med2009;361:424-5.
174.
Ferguson GG , Eliasziw M., Barr HW, et al. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients . Stroke1999;30:1751-8.
175.
Bond R., Rerkasem K., Cuffe R., et al. A systematic review of the associations between age and sex and the operative risks of carotid endarterectomy. Cerebrovasc Dis2005;20:69-77.
176.
Bond R., Rerkasem K., Shearman CP, et al. Time trends in the published risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Cerebrovasc Dis2004;18:37-46.
177.
Bond R., Rerkasem K., Naylor AR, et al. Systematic review of randomized controlled trials of patch angioplasty versus primary closure and different types of patch materials during carotid endarterectomy. J Vasc Surg2004;40:1126-35.
178.
Naylor AR, Bolia A., Abbott RJ, et al. Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial. J Vasc Surg1998;28:326-34.
179.
Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet2001 ;357:1729-37.
180.
Brooks WH, McClure RR, Jones MR, et al. Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital. J Am Coll Cardiol2001;38:1589-95.
181.
Ringleb PA , Allenberg J., Bruckmann H., et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial [published correction appears in Lancet. 2006;368:1238]. Lancet2006;368:1239-47.
182.
Coward LJ, Featherstone RL, Brown MMSafety and efficacy of endovascular treatment of carotid artery stenosis compared with carotid endarterectomy: a Cochrane systematic review of the randomized evidence. Stroke2005;36:905-11.
183.
Gurm HS, Nallamothu BK, Yadav J.Safety of carotid artery stenting for symptomatic carotid artery disease: a meta-analysis. Eur Heart J2008;29:113-9.
184.
Ederle J., Featherstone RL, Brown MMPercutaneous transluminal angioplasty and stenting for carotid artery stenosis . Cochrane Database Syst Rev2007 ;CD000515
185.
Cywinski JB , Koch CG, Krajewski LP, et al. Increased risk associated with combined carotid endarterectomy and coronary artery bypass graft surgery: a propensity-matched comparison with isolated coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth2006;20:796-802.
186.
Stoner MC, Abbott WM, Wong DR, et al. Defining the high-risk patient for carotid endarterectomy: an analysis of the prospective National Surgical Quality Improvement Program database. J Vasc Surg2006;43:285-95.
187.
Debing E., Van den Brande P.Does the type, number or combinations of traditional cardiovascular risk factors affect early outcome after carotid endarterectomy?. Eur J Vasc Endovasc Surg2006;31:622-6.
188.
Coward LJ, Featherstone RL, Brown MMPercutaneous transluminal angioplasty and stenting for carotid artery stenosis . Cochrane Database Syst Rev2004 ;CD000515
189.
Back MRCommentary: protected carotid stenting in high-surgical-risk patients: the ARCHeR results. Perspect Vasc Surg Endovasc Ther2006;18:349-51.
190.
Coward LJ , Featherstone RL, Brown MMPercutaneous transluminal angioplasty and stenting for vertebral artery stenosis . Cochrane Database Syst Rev2005 ;CD000516
191.
Crawley F. , Brown MMPercutaneous transluminal angioplasty and stenting for carotid artery stenosis . Cochrane Database Syst Rev2000 ;CD000515
Gray WAA cardiologist in the carotids. J Am Coll Cardiol2004;43:1602-5.
194.
Illig KA, Zhang R., Tanski W., et al. Is the rationale for carotid angioplasty and stenting in patients excluded from NASCET/ACAS or eligible for ARCHeR justified?. J Vasc Surg2003;37:575-81.
195.
Kasirajan K.What is the latest in inventory for carotid stenting and cerebral protection? . Perspect Vasc Surg Endovasc Ther2005;17:135-41.
196.
Naylor ARRegarding "protected carotid stenting in high-surgical-risk patients: the ARCHeR results.". J Vasc Surg2007;45:222-3.
197.
Schonholz CJ, Uflacker R., Parodi JC, et al. Is there evidence that cerebral protection is beneficial? Clinical data. J Cardiovasc Surg ( Torino) 2006;47:137-41.
198.
Devlin TG, Baxter BW, Feintuch TA, et al. The Merci Retrieval System for acute stroke: the Southeast Regional Stroke Center experience. Neurocrit Care2007 ;6:11-21.
199.
DeRubertis BG, Chaer RA, Gordon R., et al. Determining the quantity and character of carotid artery embolic debris by electron microscopy and energy dispersive spectroscopy. J Vasc Surg2007;45:716-24.
200.
Maleux G., Demaerel P., Verbeken E., et al. Cerebral ischemia after filter-protected carotid artery stenting is common and cannot be predicted by the presence of substantial amount of debris captured by the filter device. AJNR Am J Neuroradiol2006;27:1830-3.
201.
Reimers B. , Tubler T., de Donato G., et al. Endovascular treatment of in-stent restenosis after carotid artery stenting: immediate and midterm results. J Endovasc Ther2006 ;13:429-35.
202.
Imai K., Mori T., Izumoto H., et al. Successful stenting seven days after atherothrombotic occlusion of the intracranial internal carotid artery. J Endovasc Ther2006;13:254-9.
203.
Macdonald S.Is there any evidence that cerebral protection is beneficial? Experimental data. J Cardiovasc Surg ( Torino) 2006;47: 127-36.
204.
Quan VH, Huynh R., Seifert PA, et al. Morphometric analysis of particulate debris extracted by four different embolic protection devices from coronary arteries, aortocoronary saphenous vein conduits, and carotid arteries. Am J Cardiol2005;95:1415-9.
205.
Sprouse LR , Peeters P., Bosiers M.The capture of visible debris by distal cerebral protection filters during carotid artery stenting: is it predictable?. J Vasc Surg2005;41:950-5.
206.
Bush RL, Lin PH, Bianco CC, et al. Reevaluation of temporary transvenous cardiac pacemaker usage during carotid angioplasty and stenting: a safe and valuable adjunct. Vasc Endovascular Surg2004;38:229-35.
Bosiers M. , Peeters P., Verbist J., et al. Belgian experience with FilterWire EX in the prevention of embolic events during carotid stenting . J Endovasc Ther2003;10:695-701.
209.
Grube E., Colombo A., Hauptmann E., et al. Initial multicenter experience with a novel distal protection filter during carotid artery stent implantation. Catheter Cardiovasc Interv2003;58:139-46.
210.
Sievert H. , Rabe K.Role of distal protection during carotid stenting . J Interv Cardiol2002;15:499-504.
211.
Al-Mubarak N., Colombo A., Gaines PA, et al. Multicenter evaluation of carotid artery stenting with a filter protection system. J Am Coll Cardiol2002;39:841-6.
212.
Jaeger H., Mathias K., Drescher R., et al. Clinical results of cerebral protection with a filter device during stent implantation of the carotid artery. Cardiovasc Intervent Radiol2001;24:249-56.
213.
Tubler T., Schluter M., Dirsch O., et al. Balloon-protected carotid artery stenting: relationship of periprocedural neurological complications with the size of particulate debris. Circulation2001;104:2791-6.
214.
Parodi JC, La Mura R., Ferreira LM, et al. Initial evaluation of carotid angioplasty and stenting with three different cerebral protection devices. J Vasc Surg2000;32:1127-36.
215.
Ohki T., Roubin GS, Veith FJ, et al. Efficacy of a filter device in the prevention of embolic events during carotid angioplasty and stenting: an ex vivo analysis. J Vasc Surg1999;30:1034-44.
216.
Kitta Y., Obata JE, Takano H., et al. Echolucent carotid plaques predict in-stent restenosis after bare metal stenting in native coronary arteries. Atherosclerosis2008;197:177-82.
Teng ZZ, Ji GY, Chu HJ, et al. Does PGA external stenting reduce compliance mismatch in venous grafts?. Biomed Eng Online2007; 6:12.
219.
Bosiers M. , de Donato G., Deloose K., et al. Are there predictive risk factors for complications after carotid artery stenting?J Cardiovasc Surg (Torino) 2007;48:125-30.
220.
Parodi JC, Schonholz C., Parodi FE, et al. Initial 200 cases of carotid artery stenting using a reversal-of-flow cerebral protection device. J Cardiovasc Surg ( Torino) 2007;48:117-24.
221.
Peynircioglu B., Geyik S., Yavuz K., et al. Exclusion of atherosclerotic plaque from the circulation using stent-grafts: alternative to carotid stenting with a protection device?. Cardiovasc Intervent Radiol2007;30:854-60.
222.
Younis GA, Gupta K., Mortazavi A., et al. Predictors of carotid stent restenosis. Catheter Cardiovasc Interv2007;69:673-82.
223.
de Souza JM , Espinosa G., Santos MM, et al. Bilateral occlusion associated to steal phenomenon of internal carotid and left subclavian arteries: treatment by angioplasty and stenting. Surg Neurol2007 ;67:298-302.
224.
Chahwan S. , Miller MT, Pigott JP, et al. Carotid artery velocity characteristics after carotid artery angioplasty and stenting. J Vasc Surg2007;45:523-6.
225.
Kadkhodayan Y., Moran CJ, Derdeyn CP, et al. Carotid angioplasty and stent placement for restenosis after endarterectomy. Neuroradiology2007;49:357-64.
226.
de Borst GJ , Ackerstaff RG, De Vries JP, et al. Carotid angioplasty and stenting for postendarterectomy stenosis: long-term follow-up. J Vasc Surg2007;45:118-23.
227.
Protack CD , Bakken AM, Saad WA, et al. Radiation arteritis: a contraindication to carotid stenting?. J Vasc Surg2007;45:110-7.
228.
Ali ZA , Alp NJ, Lupton H., et al. Increased in-stent stenosis in ApoE knockout mice: insights from a novel mouse model of balloon angioplasty and stenting. Arterioscler Thromb Vasc Biol2007 ;27:833-40.
229.
Park B., Aiello F., Dahn M., et al. Follow-up results of carotid angioplasty with stenting as assessed by duplex ultrasound surveillance. Am J Surg2006;192:583-8.
230.
Gupta R., Al-Ali F., Thomas AJ, et al. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke2006;37:2562-6.
231.
Hauth EA, Drescher R., Jansen C., et al. Complications and follow-up after unprotected carotid artery stenting. Cardiovasc Intervent Radiol2006 ;29:511-8.
232.
Cao P. , De Rango P., Verzini F., et al. Outcome of carotid stenting versus endarterectomy: a case-control study. Stroke2006;37:1221-6.
233.
Lal BK , Hobson RWManagement of carotid restenosis . J Cardiovasc Surg (Torino) 2006;47:153-60.
234.
Halabi M., Gruberg L., Pitchersky S., et al. Carotid artery stenting in surgical high-risk patients. Catheter Cardiovasc Interv2006;67: 513-8.
235.
Eskandari MK, Longo GM, Matsumura JS, et al. Carotid stenting done exclusively by vascular surgeons: first 175 cases. Ann Surg2005;242:431-6.
236.
Morrish W. , Grahovac S., Douen A., et al. Intracranial hemorrhage after stenting and angioplasty of extracranial carotid stenosis . AJNR Am J Neuroradiol2000;21:1911-6.
237.
Ho DS, Wang Y., Chui M., et al. Epileptic seizures attributed to cerebral hyperperfusion after percutaneous transluminal angioplasty and stenting of the internal carotid artery. Cerebrovasc Dis2000;10: 374-9.
238.
Buhk JH, Cepek L., Knauth M.Hyperacute intracerebral hemorrhage complicating carotid stenting should be distinguished from hyperperfusion syndrome. AJNR Am J Neuroradiol2006;27: 1508-13.
239.
Henry M., Gopalakrishnan L., Rajagopal S., et al. Bilateral carotid angioplasty and stenting. Catheter Cardiovasc Interv2005;64: 275-82.
240.
Nicosia A. , Leotta E., Moshiri S., et al. Carotid artery stenting in the presence of contralateral carotid occlusion: mind the hyperperfusion syndrome!Ital Heart J2004;5:152-6.
241.
Chen MS, Bhatt DL, Mukherjee D., et al. Feasibility of simultaneous bilateral carotid artery stenting . Catheter Cardiovasc Interv2004;61:437-42.
242.
Hartmann M. , Weber R., Zoubaa S., et al. Fatal subarachnoid hemorrhage after carotid stenting. J Neuroradiol2004;31:63-6.
243.
Chuang YM , Wu HMEarly recognition of cerebral hyperperfusion syndrome after carotid stenting-a case report. Kaohsiung J Med Sci2001;17:489-94.
244.
Capoccia L. , Speziale F., Gazzetti M., et al. Comparative study on carotid revascularization (endarterectomy vs stenting) using markers of cellular brain injury, neuropsychometric tests, and diffusion-weighted magnetic resonance imaging. J Vasc Surg2010;51:584-91.
245.
Tedesco MM , Lee JT, Dalman RL, et al. Postprocedural microembolic events following carotid surgery and carotid angioplasty and stenting. J Vasc Surg2007;46:244-50.
246.
Kwon BJ, Han MH, Kang HS, et al. Protection filter-related events in extracranial carotid artery stenting: a single-center experience. J Endovasc Ther2006;13:711-22.
247.
Cardaioli P., Giordan M., Panfili M., et al. Complication with an embolic protection device during carotid angioplasty. Catheter Cardiovasc Interv2004;62:234-6.
248.
Eskandari MK, Najjar SF, Matsumura JS, et al. Technical limitations of carotid filter embolic protection devices. Ann Vasc Surg2007;21:403-7.
249.
Valibhoy AR , Mwipatayi BP, Sieunarine K.Fracture of a carotid stent: an unexpected complication. J Vasc Surg2007;45:603-6.
250.
Yallampalli S., Zhou W., Lin PH, et al. Delayed deformation of self-expanding stents after carotid artery stenting for postendarterectomy restenoses. J Vasc Surg2006;44:412-5.
251.
Setacci C. , de Donato G., Setacci F., et al. In-stent restenosis after carotid angioplasty and stenting: a challenge for the vascular surgeon . Eur J Vasc Endovasc Surg2005 ;29:601-7.
252.
Schillinger M., Exner M., Sabeti S., et al. Excessive carotid in-stent neointimal formation predicts late cardiovascular events . J Endovasc Ther2004;11:229-39.
253.
Rapp JH, Wakil L., Sawhney R., et al. Subclinical embolization after carotid artery stenting: new lesions on diffusion-weighted magnetic resonance imaging occur postprocedure . J Vasc Surg2007;45: 867-72.
254.
Hart JP, Peeters P., Verbist J., et al. Do device characteristics impact outcome in carotid artery stenting? . J Vasc Surg2006;44:725-30.
255.
Powell RJ, Alessi C., Nolan B., et al. Comparison of embolization protection device-specific technical difficulties during carotid artery stenting. J Vasc Surg2006;44:56-61.
256.
Safian RD, Bresnahan JF, Jaff MR, et al. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. J Am Coll Cardiol2006;47:2384-9.
257.
Hamood H., Makhoul N., Hassan A., et al. Embolic protection: limitations of current technology and novel concepts. Int J Cardiovasc Intervent2005;7:176-82.
258.
Gruberg L. , Beyar R.Cerebral embolic protection devices and percutaneous carotid artery stenting. Int J Cardiovasc Intervent2005;7:117-21.
Cil BE , Turkbey B., Canyigit M., et al. An unusual complication of carotid stenting: spontaneous rectus sheath hematoma and its endovascular management . Diagn Interv Radiol2007;13:46-8.
261.
Pipinos II , Johanning JM, Pham CN, et al. Transcervical approach with protective flow reversal for carotid angioplasty and stenting . J Endovasc Ther2005;12:446-53.
262.
Zorger N., Finkenzeller T., Lenhart M., et al. Safety and efficacy of the Perclose suture-mediated closure device following carotid artery stenting under clopidogrel platelet blockade . Eur Radiol2004;14:719-22.
263.
Gupta A., Bhatia A., Ahuja A., et al. Carotid stenting in patients older than 65 years with inoperable carotid artery disease: a single-center experience. Catheter Cardiovasc Interv2000;50:1-8.
264.
Schneider LM, Roubin GSMinimal contrast use in carotid stenting: avoiding contrast pitfalls. J Invasive Cardiol2007;19:37-8.
265.
Wholey MH, Al-Mubarek N., Wholey MHUpdated review of the global carotid artery stent registry. Catheter Cardiovasc Interv2003;60:259-66.
266.
Theiss W., Hermanek P., Mathias K., et al. Pro-CAS: a prospective registry of carotid angioplasty and stenting . Stroke2004;35: 2134-9.
267.
Kastrup A. , Groschel K., Krapf H., et al. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke2003;34:813-9.
268.
Barbato JE , Dillavou E., Horowitz MB, et al. A randomized trial of carotid artery stenting with and without cerebral protection. J Vasc Surg2008;47:760-5.
269.
Qureshi AI , Kirmani JF, Divani AA, et al. Carotid angioplasty with or without stent placement versus carotid endarterectomy for treatment of carotid stenosis: a meta-analysis. Neurosurgery2005;56:1171-9.
270.
Brahmanandam S., Ding EL, Conte MS, et al. Clinical results of carotid artery stenting compared with carotid endarterectomy. J Vasc Surg2008;47:343-9.
271.
Luebke T., Aleksic M., Brunkwall J.Meta-analysis of randomized trials comparing carotid endarterectomy and endovascular treatment. Eur J Vasc Endovasc Surg2007;34:470-9.
272.
Murad MH, Flynn DN, Elamin MB, et al. Endarterectomy vs stenting for carotid artery stenosis: a systematic review and meta-analysis. J Vasc Surg2008 ;48:487-93.
273.
Meier P., Knapp G., Tamhane U., et al. Short term and intermediate term comparison of endarterectomy versus stenting for carotid artery stenosis: systematic review and meta-analysis of randomised controlled clinical trials. BMJ2010;340:c467.
274.
Hobson RWCREST (Carotid Revascularization Endarterectomy versus Stent Trial): background, design, and current status. Semin Vasc Surg2000;13:139-43.
275.
Hobson RW, Howard VJ, Roubin GS, et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase . J Vasc Surg2004;40:1106-11.
276.
Roubin GS, Clark WM, Chakhtoura EY, et al. Low complication rates for carotid artery stenting in the credentialling phase of the carotid revascularization endarterectomy versus stenting trial . Stroke2006;37:620. Abstract.
277.
Moore WS, Kempczinski RF, Nelson JJ, et al. Recurrent carotid stenosis: results of the Asymptomatic Carotid Atherosclerosis Study. Stroke1998;29:2018-25.
278.
Matsagas MI , Bali C., Arnaoutoglou E., et al. Carotid endarterectomy with bovine pericardium patch angioplasty: mid-term results. Ann Vasc Surg2006;20:614-9.
279.
Cunningham EJ, Bond R., Mehta Z., et al. Long-term durability of carotid endarterectomy for symptomatic stenosis and risk factors for late postoperative stroke. Stroke2002 ;33:2658-63.
280.
Bond R., Rerkasem K., Naylor R., et al. Patches of different types for carotid patch angioplasty. Cochrane Database Syst Rev2004;CD000071
281.
Cikrit DF, Larson DM, Sawchuk AP, et al. Discretionary carotid patch angioplasty leads to good results . Am J Surg2006;192:e46-50.
282.
Cunningham EJ, Bond R., Mayberg MR, et al. Risk of persistent cranial nerve injury after carotid endarterectomy. J Neurosurg2004;101:445-8.
283.
Rockman CB , Halm EA, Wang JJ, et al. Primary closure of the carotid artery is associated with poorer outcomes during carotid endarterectomy . J Vasc Surg2005;42:870-7.
284.
Hansen F., Lindblad B., Persson NH, et al. Can recurrent stenosis after carotid endarterectomy be prevented by low-dose acetylsalicylic acid? A double-blind, randomised and placebo-controlled study. Eur J Vasc Surg1993;7:380-5.
285.
Petrik PV , Gelabert HA, Moore WS, et al. Cigarette smoking accelerates carotid artery intimal hyperplasia in a dose-dependent manner. Stroke1995;26:1409-14.
286.
Gelabert HA , el-Massry S., Moore WSCarotid endarterectomy with primary closure does not adversely affect the rate of recurrent stenosis . Arch Surg1994 ;129:648-54.
287.
Salvian A. , Baker JD, Machleder HI, et al. Cause and noninvasive detection of restenosis after carotid endarterectomy. Am J Surg1983;146:29-34.
288.
AbuRahma AF , Robinson PA, Saiedy S., et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: long-term follow-up. J Vasc Surg1998;27:222-32.
289.
Lord RS, Raj TB, Stary DL, et al. Comparison of saphenous vein patch, polytetrafluoroethylene patch, and direct arteriotomy closure after carotid endarterectomy: part I: perioperative results. J Vasc Surg1989;9:521-9.
290.
Eikelboom BC, Ackerstaff RG, Hoeneveld H., et al. Benefits of carotid patching: a randomized study. J Vasc Surg1988;7:240-7.
291.
Curley S., Edwards WS, Jacob TPRecurrent carotid stenosis after autologous tissue patching. J Vasc Surg1987;6:350-4.
292.
Awad IA, Little JRPatch angioplasty in carotid endarterectomy: advantages, concerns, and controversies . Stroke1989;20:417-22.
293.
Bernstein EF, Torem S., Dilley RBDoes carotid restenosis predict an increased risk of late symptoms, stroke, or death?. Ann Surg1990;212:629-36.
294.
Nicholls SC , Phillips DJ, Bergelin RO, et al. Carotid endarterectomy: relationship of outcome to early restenosis. J Vasc Surg1985;2:375-81.
295.
O’Donnell TF Jr., Callow AD, Scott G., et al. Ultrasound characteristics of recurrent carotid disease: hypothesis explaining the low incidence of symptomatic recurrence . J Vasc Surg1985;2:26-41.
296.
Zierler RE , Bandyk DF, Thiele BL, et al. Carotid artery stenosis following endarterectomy. Arch Surg1982;117:1408-15.
Hertzer NR , Beven EG, O’Hara PJ, et al. A prospective study of vein patch angioplasty during carotid endarterectomy: three-year results for 801 patients and 917 operations. Ann Surg1987;206:628-35.
299.
Hertzer NR , Martinez BD, Benjamin SP, et al. Recurrent stenosis after carotid endarterectomy . Surg Gynecol Obstet1979;149:360-4.
300.
DeGroote RD , Lynch TG, Jamil Z., et al. Carotid restenosis: long-term noninvasive follow-up after carotid endarterectomy. Stroke1987;18:1031-6.
301.
Wehman JC, Hanel RA, Guidot CA, et al. Atherosclerotic occlusive extracranial vertebral artery disease: indications for intervention, endovascular techniques, short-term and long-term results. J Interv Cardiol2004;17:219-32.
302.
Wityk RJ, Chang HM, Rosengart A., et al. Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol1998;55:470-8.
303.
Chimowitz MI, Lynn MJ, Howlett-Smith H., et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med2005;352:1305-16.
304.
Hornig CR, Lammers C., Buttner T., et al. Long-term prognosis of infratentorial transient ischemic attacks and minor strokes. Stroke1992;23:199-204.
305.
Marquardt L., Kuker W., Chandratheva A., et al. Incidence and prognosis of ≥50% symptomatic vertebral or basilar artery stenosis: prospective population-based study. Brain2009;132:982-8.
306.
Blacker DJ , Flemming KD, Wijdicks EFRisk of ischemic stroke in patients with symptomatic vertebrobasilar stenosis undergoing surgical procedures. Stroke2003;34:2659-63.
307.
Savitz SI, Caplan LRVertebrobasilar disease. N Engl J Med2005 ;352:2618-26.
308.
Caplan LRAtherosclerotic vertebral artery disease in the neck. Curr Treat Options Cardiovasc Med2003;5:251-6.
309.
Canyigit M. , Arat A., Cil BE, et al. Management of vertebral stenosis complicated by presence of acute thrombus. Cardiovasc Intervent Radiol2007;30:317-20.
Kasner SE, Lynn MJ, Chimowitz MI, et al. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology2006;67:1275-8.
312.
Benesch CG , Chimowitz MI, WASID Investigators Best treatment for intracranial arterial stenosis? 50 years of uncertainty. Neurology2000;55:465-6.
313.
Grotta JC, Norris JW, Kamm B., et al. Prevention of stroke with ticlopidine: who benefits most?. Neurology1992;42:111-5.
314.
Sivenius J. , Riekkinen PJ, Smets P., et al. The European Stroke Prevention Study (ESPS): results by arterial distribution. Ann Neurol1991;29:596-600.
315.
Berguer R. , Flynn LM, Kline RA, et al. Surgical reconstruction of the extracranial vertebral artery: management and outcome . J Vasc Surg2000;31:9-18.
316.
Berguer R.Suboccipital approach to the distal vertebral artery. J Vasc Surg1999;30:344-9.
317.
Berguer R. , Morasch MD, Kline RAA review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease. J Vasc Surg1998;27:852-9.
318.
Spetzler RF , Hadley MN, Martin NA, et al. Vertebrobasilar insufficiency: part 1: microsurgical treatment of extracranial vertebrobasilar disease. J Neurosurg1987;66:648-61.
319.
Hopkins LN , Martin NA, Hadley MN, et al. Vertebrobasilar insufficiency: part 2: microsurgical treatment of intracranial vertebrobasilar disease. J Neurosurg1987;66:662-74.
320.
Hopkins LN , Budny JLComplications of intracranial bypass for vertebrobasilar insufficiency. J Neurosurg1989;70:207-11.
321.
Hopkins LN , Budny JL, Castellani D.Extracranial-intracranial arterial bypass and basilar artery ligation in the treatment of giant basilar artery aneurysms . Neurosurgery1983;13:189-94.
322.
Hopkins LN , Budny JL, Spetzler RFRevascularization of the rostral brain stem . Neurosurgery1982 ;10:364-9.
323.
Berguer R. , Bauer RBVertebral artery reconstruction: a successful technique in selected patients. Ann Surg1981 ;193:441-7.
324.
Berguer R. , Bauer RBVertebrobasilar arterial occlusive diesase: medical and surgical management . New York, NY: Raven Press; 1984.
325.
Roon AJ, Ehrenfeld WK, Cooke PB, et al. Vertebral artery reconstruction. Am J Surg1979;138:29-36.
326.
Malone JM, Moore WS, Hamilton R., et al. Combined carotid-vertebral vascular disease: a new surgical approach. Arch Surg1980;115:783-5.
327.
Caplan L. , Tettenborn B.Embolism in the posterior circulation. In: Berguer R, Caplan L, editors. Vertebrobailar Arterial Disease. St. Louis, Mo : Quality Medical, 1992.
328.
Thevenet A. , Ruotolo C.Surgical repair of vertebral artery stenoses . J Cardiovasc Surg (Torino ) 1984;25:101-10.
329.
Edwards WH , Mulherin JL Jr.The surgical reconstruction of the proximal subclavian and vertebral artery. J Vasc Surg1985;2:634-42.
330.
Diaz FG, Ausman JI, de los Reyes RA, et al. Surgical reconstruction of the proximal vertebral artery. J Neurosurg1984;61:874-81.
331.
Imparato AM , Riles TS, Kim GECervical vertebral angioplasty for brain stem ischemia. Surgery1981;90:842-52.
332.
Eberhardt O., Naegele T., Raygrotzki S., et al. Stenting of vertebrobasilar arteries in symptomatic atherosclerotic disease and acute occlusion: case series and review of the literature. J Vasc Surg2006 ;43:1145-54.
333.
Law MM , Colburn MD, Moore WS, et al. Carotid-subclavian bypass for brachiocephalic occlusive disease: choice of conduit and long-term follow-up. Stroke1995;26:1565-71.
334.
AbuRahma AF , Bates MC, Stone PA, et al. Angioplasty and stenting versus carotid-subclavian bypass for the treatment of isolated subclavian artery disease. J Endovasc Ther2007;14:698-704.
335.
De Vries JP , Jager LC, van den Berg JC, et al. Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: long-term results. J Vasc Surg2005;41:19-23.
336.
Sullivan TM , Gray BH, Bacharach JM, et al. Angioplasty and primary stenting of the subclavian, innominate, and common carotid arteries in 83 patients. J Vasc Surg1998;28:1059-65.
337.
Brountzos EN , Petersen B., Binkert C., et al. Primary stenting of subclavian and innominate artery occlusive disease: a single center’s experience. Cardiovasc Intervent Radiol2004;27:616-23.
338.
Hadjipetrou P. , Cox S., Piemonte T., et al. Percutaneous revascularization of atherosclerotic obstruction of aortic arch vessels. J Am Coll Cardiol1999;33:1238-45.
339.
Whitbread T. , Cleveland TJ, Beard JD, et al. A combined approach to the treatment of proximal arterial occlusions of the upper limb with endovascular stents . Eur J Vasc Endovasc Surg1998;15:29-35.
340.
Rodriguez-Lopez JA, Werner A., Martinez R., et al. Stenting for atherosclerotic occlusive disease of the subclavian artery. Ann Vasc Surg1999;13:254-60.
341.
Van Noord BA, Lin AH, Cavendish JJRates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting . Vasc Health Risk Manag2007;3:759-62.
342.
Peterson BG , Resnick SA, Morasch MD, et al. Aortic arch vessel stenting: a single-center experience using cerebral protection. Arch Surg2006;141:560-3.
343.
Filippo F. , Francesco M., Francesco R., et al. Percutaneous angioplasty and stenting of left subclavian artery lesions for the treatment of patients with concomitant vertebral and coronary subclavian steal syndrome . Cardiovasc Intervent Radiol2006;29:348-53.
344.
van Hattum ES, De Vries JP, Lalezari F., et al. Angioplasty with or without stent placement in the brachiocephalic artery: feasible and durable?. A retrospective cohort study. J Vasc Interv Radiol2007;18:1088-93.
345.
Naylor AR, Cuffe RL, Rothwell PM, et al. A systematic review of outcomes following staged and synchronous carotid endarterectomy and coronary artery bypass. Eur J Vasc Endovasc Surg2003;25:380-9.
Brener B. , Hermans H., Eisenbud D., et al. The management of patients requiring coronary bypass and carotid endarterectomy. In: Moore W S, editor. Surgery for Cerebrovascular Disease. 2nd edition. Philadelphia, Pa: W.B. Saunders, 1996:278-9.
348.
Ricotta JJ , Wall LP, Blackstone E.The influence of concurrent carotid endarterectomy on coronary bypass: a case-controlled study . J Vasc Surg2005;41:397-401.
349.
Byrne J., Darling RC III, Roddy SP, et al. Combined carotid endarterectomy and coronary artery bypass grafting in patients with asymptomatic high-grade stenoses: an analysis of 758 procedures . J Vasc Surg2006;44:67-72.
350.
Dubinsky RM , Lai SMMortality from combined carotid endarterectomy and coronary artery bypass surgery in the US. Neurology2007;68:195-7.
351.
Kougias P. , Kappa JR, Sewell DH, et al. Simultaneous carotid endarterectomy and coronary artery bypass grafting: results in specific patient groups. Ann Vasc Surg2007;21:408-14.
352.
Van der Heyden J., Suttorp MJ, Bal ET, et al. Staged carotid angioplasty and stenting followed by cardiac surgery in patients with severe asymptomatic carotid artery stenosis: early and long-term results. Circulation2007;116:2036-42.
353.
Timaran CH , Rosero EB, Smith ST, et al. Trends and outcomes of concurrent carotid revascularization and coronary bypass. J Vasc Surg2008;48:355-60.
354.
Slovut DP, Olin JWFibromuscular dysplasia. N Engl J Med2004 ;350:1862-71.
355.
Olin JWRecognizing and managing fibromuscular dysplasia. Cleve Clin J Med2007;74:273-82.
356.
Zhou W., Bush RL, Lin PL, et al. Fibromuscular dysplasia of the carotid artery. J Am Coll Surg2005;200:807.
Stahlfeld KR, Means JR, Didomenico P.Carotid artery fibromuscular dysplasia. Am J Surg2007;193:71-2.
359.
Ballotta E. , Thiene G., Baracchini C., et al. Surgical vs medical treatment for isolated internal carotid artery elongation with coiling or kinking in symptomatic patients: a prospective randomized clinical study . J Vasc Surg2005;42:838-46.
360.
Assadian A. , Senekowitsch C., Assadian O., et al. Combined open and endovascular stent grafting of internal carotid artery fibromuscular dysplasia: long term results . Eur J Vasc Endovasc Surg2005;29: 345-9.
361.
Finsterer J., Strassegger J., Haymerle A., et al. Bilateral stenting of symptomatic and asymptomatic internal carotid artery stenosis due to fibromuscular dysplasia . J Neurol Neurosurg Psychiatry2000;69:683-6.
362.
DiLuna ML, Bydon M., Gunel M., et al. Neurological picture: complications from cervical intra-arterial heroin injection. J Neurol Neurosurg Psychiatry2007;78:1198.
363.
Zaidat OO, Frank J.Vertebral artery dissection with amphetamine abuse. J Stroke Cerebrovasc Dis2001;10:27-9.
364.
Schievink WISpontaneous dissection of the carotid and vertebral arteries. N Engl J Med2001;344:898-906.
365.
Kawchuk GN , Jhangri GS, Hurwitz EL, et al. The relation between the spatial distribution of vertebral artery compromise and exposure to cervical manipulation. J Neurol2008;255:371-7.
366.
Cohen JE, Gomori JM, Umansky F.Endovascular management of symptomatic vertebral artery dissection achieved using stent angioplasty and emboli protection device. Neurol Res2003;25:418-22.
367.
Shah Q., Messe SRCervicocranial arterial dissection. Curr Treat Options Neurol2007;9:55-62.
368.
Turowski B. , Hanggi D., Siebler M.Intracranial bilateral vertebral artery dissection during anticoagulation after cerebral venous and sinus thrombosis (CSVT). Acta Neurochir ( Wien) 2007;149: 793-7.
369.
Lyrer P., Engelter S.Antithrombotic drugs for carotid artery dissection. Stroke2004;35:613-4.